Kathleen Mullane to Adenosine Monophosphate
This is a "connection" page, showing publications Kathleen Mullane has written about Adenosine Monophosphate.
Connection Strength
0.565
-
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk? Clin Infect Dis. 2021 12 06; 73(11):e3990-e3995.
Score: 0.200
-
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 09 15; 324(11):1048-1057.
Score: 0.184
-
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 11 05; 383(19):1827-1837.
Score: 0.180